Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts

Journal of Psychiatric Research

Volumn 47, Issue 6, 2013, Pages 718-725

  Liemburg, Edith ^a   Castelein, Stynke ^a,b   Stewart, Roy ^a   van der Gaag, Mark ^c,d   Aleman, André ^a,e   Knegtering, Henderikus ^a,b   Kahn, René S ^f   Linszen, Don H ^d   van Os, Jim ^g   Wiersma, Durk ^a   Bruggeman, Richard ^a   Cahn, Wiepke ^f   de Haan, Lieuwe ^d   Krabbendam, Lydia ^g   Myin Germeys, Inez ^g  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Center for Mental Healthcare   (Netherlands)

^c PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Factor analysis; Negative symptoms; Psychotic disorder; Schizophrenia

Indexed keywords

ADULT; ARTICLE; AVOIDANCE BEHAVIOR; AVOLITION; BLUNTED AFFECT; BODY POSTURE; DISEASE SEVERITY; DSM-5; EMOTIONAL WITHDRAWAL; EMOTIONALITY; EXPRESSIVE DEFICIT; FACTORIAL ANALYSIS; FEMALE; GESTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MOTOR RETARDATION; NEGATIVE SYNDROME; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL INTERACTION;

EID: 84875908782     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.01.024     Document Type: Article

References (80)

1. Albright J.J., Park H.M. Confirmatory factor analysis using amos, LISREL, Mplus, and SAS/STAT CALIS 2009, Indiana University: The University Information Technology Services (UITS) Center for Statistical and Mathematical Computing.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Washington, DC. 4th ed.
3. Andreasen N.C. Scale for the assessment of negative symptoms 1983, University of Iowa Press, Iowa City.
4. Andreasen N.C., Flaum M. Schizophrenia: the characteristic symptoms. Schizophrenia Bulletin 1991, 17(1):27-49.
5. Arbabi M., Bagheri M., Rezaei F., Ahmadi-Abhari S.A., Tabrizi M., Khalighi-Sigaroudi F., et al. A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia. Psychopharmacology 2012 Apr, 220(3):591-598.
6. Bell M., Milstein R., Beam-Goulet J., Lysaker P., Cicchetti D. The positive and negative syndrome scale and the brief psychiatric rating scale. Reliability, comparability, and predictive validity. The Journal of Nervous and Mental Disease 1992 Nov, 180(11):723-728.
7. Bell M.D., Corbera S., Johannesen J.K., Fiszdon J.M., Wexler B.E. Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?. Schizophrenia Bulletin 2011 Oct 5.
8. Bell M.D., Lysaker P.H., Beam-Goulet J.L., Milstein R.M., Lindenmayer J.P. Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale. Psychiatry Research 1994 Jun, 52(3):295-303.
9. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophrenia Bulletin 2006 Apr, 32(2):238-245.
10. Bobo W.V., Woodward N.D., Sim M.Y., Jayathilake K., Meltzer H.Y. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial. Schizophrenia Research 2011 Aug, 130(1-3):106-113.
11. Clarke D.E., Ko J.Y., Kuhl E.A., Van Reekum R., Salvador R., Marin R.S. Are the available apathy measures reliable and valid? A review of the psychometric evidence. Journal of Psychosomatic Research 2011 Jan, 70(1):73-97.
12. Cole D.A., Ciesla J.A., Steiger J.H. The insidious effects of failing to include design-driven correlated residuals in latent-variable covariance structure analysis. Psychological Methods 2007 Dec, 12(4):381-398.
13. Cole M.W., Anticevic A., Repovs G., Barch D. Variable global dysconnectivity and individual differences in schizophrenia. Biological Psychiatry 2011 Jul 1, 70(1):43-50.
14. Davis J.M., Chen N. The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials. The Journal of Clinical Psychiatry 2001 Oct, 62(10):757-771.
15. Dollfus S., Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. European Psychiatry: The Journal of the Association of European Psychiatrists 1995, 10(2):97-106.
16. Dollfus S., Petit M. Stability of positive and negative symptoms in schizophrenic patients: a 3-year follow-up study. European Psychiatry: The Journal of the Association of European Psychiatrists 1995, 10(5):228-236.
17. Drake R.J., Dunn G., Tarrier N., Haddock G., Haley C., Lewis S. The evolution of symptoms in the early course of non-affective psychosis. Schizophrenia Research 2003 Sep 1, 63(1-2):171-179.
18. Emsley R., Rabinowitz J., Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophrenia Research 2003 May 1, 61(1):47-57. RIS-INT-35 Early Psychosis Global Working Group.
19. Fitzgerald P.B., de Castella A.R., Brewer K., Filia K., Collins J., Davey P., et al. A confirmatory factor analytic evaluation of the pentagonal PANSS model. Schizophrenia Research 2003 May 1, 61(1):97-104.
20. Fitzgerald P.B., Rolfe T.J., Brewer K., Filia K., Collins J., Filia S., et al. Depressive, positive, negative and parkinsonian symptoms in schizophrenia. The Australian and New Zealand Journal of Psychiatry 2002 Jun, 36(3):340-346.
21. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatrica Scandinavica 2001 May, 103(5):387-392.
22. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophrenia Bulletin 2010 Mar, 36(2):359-369.
23. Fredrikson D.H., Steiger J.M., MacEwan G.W., Altman S., Kopala L.C., Flynn S.W., et al. PANSS symptom factors in schizophrenia. Schizophrenia Research 1997, 24(1):15.
24. Fresan A., De la Fuente-Sandoval C., Loyzaga C., Garcia-Anaya M., Meyenberg N., Nicolini H., et al. A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients. Schizophrenia Research 2005 Jan 1, 72(2-3):123-129.
25. Gerbing D.W., Anderson J.C. On the meaning of within-factor correlated measurement errors. Journal of Consumer Research 1984, 11(1):572-580.
26. Grant P.M., Huh G.A., Perivoliotis D., Stolar N.M., Beck A.T. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry 2012 Feb, 69(2):121-127.
27. Higashima M., Urata K., Kawasaki Y., Maeda Y., Sakai N., Mizukoshi C., et al. P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia. Biological Psychiatry 1998 Jul 15, 44(2):115-120.
28. Horan W.P., Kring A.M., Blanchard J.J. Anhedonia in schizophrenia: a review of assessment strategies. Schizophrenia Bulletin 2006 Apr, 32(2):259-273.
29. Hu L., Bentler P.M. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychological Bulletin 1998, 6(1):424-453.
30. Jöreskog K.G., Sörbom D. LISREL 8 User's reference guide 2011, Scientific Software International, Inc., Lincolnwood. 2nd ed.
31. Kawasaki Y., Maeda Y., Sakai N., Higashima M., Urata K., Yamaguchi N., et al. Evaluation and interpretation of symptom structures in patients with schizophrenia. Acta Psychiatrica Scandinavica 1994 Jun, 89(6):399-404.
32. Kay S., Fitzbein A., Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 1987, 13:231-267.
33. Kay S.R., Sevy S. Pyramidical model of schizophrenia. Schizophrenia Bulletin 1990, 16(3):537-545.
34. Keefe R.S., Harvey P.D., Lenzenweger M.F., Davidson M., Apter S.H., Schmeidler J., et al. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Research 1992 Nov, 44(2):153-165.
35. Kendler K.S., Lieberman J.A., Walsh D. The structured interview for schizotypy (SIS): a preliminary report. Schizophrenia Bulletin 1989, 15(4):559-571.
36. Kimhy D., Yale S., Goetz R.R., McFarr L.M., Malaspina D. The factorial structure of the schedule for the deficit syndrome in schizophrenia. Schizophrenia Bulletin 2006 Apr, 32(2):274-278.
37. Kirkpatrick B., Buchanan R.W., McKenney P.D., Alphs L.D., Carpenter W.T. The Schedule for the deficit syndrome: an instrument for research in schizophrenia. Psychiatry Research 1989, 30(2):119-123.
38. Kirkpatrick B., Buchanan R.W., Ross D.E., Carpenter W.T. A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry 2001 Feb, 58(2):165-171.
39. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin 2006 Apr, 32(2):214-219.
40. Kirkpatrick B., Fischer B. Subdomains within the negative symptoms of schizophrenia: commentary. Schizophrenia Bulletin 2006 Apr, 32(2):246-249.
41. Konings M., Bak M., Hanssen M., Van Os J., Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatrica Scandinavica 2006 Jul, 114(1):55-61.
42. Lako I.M., Bruggeman R., Knegtering H., Wiersma D., Schoevers R.A., Slooff C.J., et al. A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. Journal of Affective Disorders 2012 Sep, 140(1):38-47.
43. Lancon C., Aghababian V., Llorca P.M., Auquier P. Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis. Acta Psychiatrica Scandinavica 1998 Nov, 98(5):369-376.
44. Lancon C., Aghababian V., Llorca P.M., Bernard D., Auquier P. An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale. Canadian journal of psychiatry. Revue canadienne de psychiatrie 1999 Nov, 44(9):893-900.
45. Lancon C., Auquier P., Nayt G., Reine G. Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophrenia Research 2000 May 5, 42(3):231-239.
46. Lee K.H., Harris A.W., Loughland C.M., Williams L.M. The five symptom dimensions and depression in schizophrenia. Psychopathology 2003, 36(5):226-233.
47. Lei M., Lomax R.G. The effect of varying degrees of nonnormality in structural equation modeling. Structural Equation Modeling 2005, 12(1):1-27.
48. Lépine J.P., Piron J.J., Charpatot E. Factor analysis of the PANSS in schizophrenia. Psychiatry today: accomplishments and promises 1989, Exepta Medica, Amsterdam. C.N. Stefanis (Ed.).
49. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. Five-factor model of schizophrenia. Initial validation. The Journal of Nervous and Mental Disease 1994, 182(11):631-638.
50. Lindenmayer J.P., Bernstein-Hyman R., Grochowski S. A new five factor model of schizophrenia. The Psychiatric Quarterly 1994, 65(4):299-322.
51. Lindenmayer J.P., Czobor P., Volavka J., Lieberman J.A., Citrome L., Sheitman B., et al. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. The Journal of Clinical Psychiatry 2004 Apr, 65(4):551-556.
52. Lindström E., Von Knorring L. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia. Nordish Journal of Psychiatry 1993, 47(4):257-263.
53. Loas G., Noisette C., Legrand A., Delahousse J. A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS. L'Encephale 1997, 23(1):10-18.
54. Lykouras L., Oulis P., Psarros K., Daskalopoulou E., Botsis A., Christodoulou G.N., et al. Five-factor model of schizophrenic psychopathology: how valid is it?. European Archives of Psychiatry and Clinical Neuroscience 2000, 250(2):93-100.
55. Lyne J.P., Kinsella A., O'Donoghue B. Can we combine symptom scales for collaborative research projects?. Journal of Psychiatric Research 2012 Feb, 46(2):233-238.
56. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. Journal of Clinical Psychiatry 1997, 58(12):538-564.
57. Marsch H.W., Hau K.-, Wen Z. In search of golden rules: comment on hypothesis testing approaches to setting cut-off values for indices and dangers in overgeneralizing Hu and Bentler's (1999). Structural Equation Modeling 2004, 11(3):320-341.
58. Mass R., Schoemig T., Hitschfeld K., Wall E., Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophrenia Bulletin 2000, 26(1):167-177.
59. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., et al. Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research. Clinical Psychology Review 2011 Feb, 31(1):161-168.
60. Mueser K.T., McGurk S.R. Schizophrenia. Lancet 2004 Jun 19, 363(9426):2063-2072.
61. Oorschot M., Lataster T., Thewissen V., Lardinois M., Wichers M., Van Os J., et al. Emotional experience in negative symptoms of schizophrenia-No evidence for a generalized hedonic deficit. Schizophrenia Bulletin 2013 Jan, 39(1):217-225.
62. Peralta V., Cuesta M.J. Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models. The American Journal of Psychiatry 1995 Oct, 152(10):1450-1457.
63. Pinkham A.E., Penn D.L., Perkins D.O., Lieberman J. Implications for the neural basis of social cognition for the study of schizophrenia. The American Journal of Psychiatry 2003 May, 160(5):815-824.
64. Powel D.A., Schafer W.D. The robustness of the likelihood ratio chi-square test for structural equation models: a meta-analysis. Journal of Educational and Behavioural Statistics 2001, 26(1):105-132.
65. Rabany L., Weiser M., Werbeloff N., Levkovitz Y. Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS. Schizophrenia Research 2011 Mar, 126(1-3):226-230.
66. Rapado-Castro M., Soutullo C., Fraguas D., Arango C., Paya B., Castro-Fornieles J., et al. Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale. The Journal of Clinical Psychiatry 2010 Mar, 71(3):327-337.
67. Reichenberg A., Rieckmann N., Harvey P.D. Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study. Journal of Abnormal Psychology 2005 Aug, 114(3):363-372.
68. Slade M., Beck A., Bindman J., Thornicroft G., Wright S. Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS. British Journal of Psychiatry 1999, 174:404-408.
69. Stevens J. Applied multivariate analysis in social sciences 1996, Lawrence Erlbaum, Mahwah, NJ.
70. Tabachnik B.G., Fidell L.S. Using multivariate statistics 2007, Pearson Education, Boston. 5th ed.
71. Trompenaars F.J., Masthoff E.D., Van Heck G.L., Hodiamont P.P., De Vries J. Tent validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. Quality of Life Research 2005, 14(1):151-160.
72. Van den Oord E.J., Rujescu D., Robles J.R., Giegling I., Birrell C., Bukszar J., et al. Factor structure and external validity of the PANSS revisited. Schizophrenia Research 2006 Feb 28, 82(2-3):213-223.
73. Van der Gaag M., Cuijpers A., Hoffman T., Remijsen M., Hijman R., de Haan L., et al. The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions. Schizophrenia Research 2006, 85(1-3):273-279.
74. Van der Gaag M., Hoffman T., Remijsen M., Hijman R., de Haan L., van Meijel B., et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophrenia Research 2006, 85(1-3):280-287.
75. Vilaplana M., Ochoa S., Martinez A., Villalta V., Martinez-Leal R., Puigdollers E., et al. Validation in Spanish population of the family objective and subjective burden interview (ECFOS-II) for relatives of patients with schizophrenia. Actas Espanolas de Psiquiatria 2007, 35(6):372-381.
76. Vollema M.G., Ormel J. The reliability of the structured interview for schizotypy-revised. Schizophrenia Bulletin 2000, 26(3):619-629.
77. Wechsler D. WAIS-III: Wechsler adult intelligence scale. Administration and scoring manual 1997, Psychological Corporation, San Antonio, TX. 3rd ed.
78. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997, 30(5):263-274.
79. Wolthaus J.E., Dingemans P.M., Schene A.H., Linszen D.H., Knegtering H., Holthausen E.A., et al. Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology 2000 Jul, 150(4):399-403.
80. Yuan K.-, Bentler P.M. Normal theory based test statistics in structural equation modeling. British Journal of Mathematical and Statistical Psychology 1998, 51:289-309.